df-mp Patentanwälte Rechtsanwälte PartG mbB
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
df-mp Patentanwälte Rechtsanwälte PartG mbB advises a range of clients, with particular expertise in the life sciences, pharmaceuticals and chemistry industries. The group receives mandates from biotechnology and pharmaceutical clients regarding both patent litigation and prosecutions, including patent infringement and revocation actions before the UPC, while also advising clients on freedom-to-operate and patent validity issues. Jointly leading the group are Sandra Pohlman, Hans Ulrich Dörries, and Elisabeth Greiner. Pohlman advises life sciences clients, handling oppositions and prosecutions before the European Patent Office. Dörries assists clients from the molecular biology, biotechnology, immunology, pharmaceuticals and polymer chemistry sectors, while Greiner focuses on opposition proceedings and litigates both English & Welsh and German patents. Another key name is David Molnia, who represents clients before the European Patent Office and German Patent and Trademark Office, among others.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘Very flexible and high level of understanding of clients' needs.’
- 'Sandra Pohlman is a star - and not only in Europe. She is a world-class attorney and one of my favourite outside counsel to work with. She has incredible litigation instincts and I trust her judgement implicitly.'
Key clients
- Biogen MA Inc.
- Biocon